Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

Share Price is delayed by 15 minutes
Get Live Data
4,514.00    110.00 (2.50%)
Bid:
4,514.00
Ask:
4,516.00
Spread: 2.00 (0.044%)
Market Cap: £97.57b
BATS Live PriceLast checked at - London Stock Exchange

Intraday British American Tobacco Share Chart

Board Update - Chair Extension and SID Appointment

10 Feb 2026 09:00

RNS Number : 3201S
British American Tobacco PLC
10 February 2026
 

British American Tobacco p.l.c. (the "Company" or "BAT")

 

10 February 2026 

 

Board Update - Chair Extension and Senior Independent Director Appointment

The Company announces that, following a comprehensive Chair succession process, the Board has decided to extend Luc Jobin's tenure as Chair. This extension is for a period of up to two years until the Company's Annual General Meeting (AGM) in April 2028, during which the search process will continue with the aim of appointing a new Chair within that time. Luc will continue to stand for annual re‑election at the Company's AGM.

 

Luc was appointed to the Board in July 2017, and as Chair in April 2021. In July 2026, he will have served nine years on the Board, including five years as Chair. A comprehensive Chair succession process led by Holly Keller Koeppel, the Senior Independent Director, together with the Nominations Committee was supported by external advisers.

 

Holly Keller Koeppel, Senior Independent Director, said:

"Luc is a proven and respected Chair who continues to lead the Board effectively whilst providing thoughtful challenge and support to management through the delivery of the Group's transformation agenda. Luc's prior service on the Board means that an extension beyond July 2026 would represent a departure from the UK Corporate Governance Code nine-year tenure recommendation. The Board continues to be committed to maintaining high standards of corporate governance and recognises the importance of Board refreshment. Having run a thorough succession process, evaluating a number of credible candidates against the Board's criteria including effective global leadership at scale and the skills we are seeking to lead BAT through its continued transformation, the Board concluded that extending Luc's tenure is in the best interests of BAT at this time. An extension period of up to two years removes uncertainty during this important phase of the Group's transformation, while providing the Nominations Committee with sufficient flexibility to appoint the right candidate for BAT."

Having served on the Board since July 2017, Holly Keller Koeppel will step down from the Board at the conclusion of the 2026 AGM and Karen Guerra will be appointed to the role of Senior Independent Director, subject to re-election. Karen has been closely involved in the Chair succession process to date and is well placed to lead the refreshed search process and support an orderly transition.

 

Luc Jobin, Chair, commented:

"I would like to thank Holly for her extensive contribution to the Board, including as Senior Independent Director and Chair of the Audit Committee before that. We wish her well in her future board endeavours. I look forward to welcoming Karen as Senior Independent Director. Her experience and insight will be invaluable as the search for my successor continues."

Enquiries

Media Centre

press_office@bat.com | @BATplc

Investor Relations

Victoria Buxton | IR_team@bat.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATLMLTMTMMBMF
Date   Source Headline
5th Jun 20263:15 pmRNSDirector/PDMR Shareholding
4th Jun 20262:30 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNS2026 H1 Pre-Close Trading Update
1st Jun 202612:20 pmRNSIssue of Shares
1st Jun 202612:15 pmRNSTotal Voting Rights
1st Jun 202612:00 pmRNSTransaction in Own Shares
27th May 20264:15 pmRNSDirector/PDMR Shareholding
26th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20261:15 pmRNSTransaction in Own Shares
21st May 20264:30 pmRNSDirector Declaration
18th May 20263:00 pmRNSDirector/PDMR Shareholding
18th May 202612:00 pmRNSTransaction in Own Shares
13th May 202612:00 pmRNSDirector/PDMR Shareholding
11th May 202611:45 amRNSAdmission to Trading
11th May 202611:30 amRNSTransaction in Own Shares
8th May 20264:30 pmRNSDirector/PDMR Shareholding
8th May 20264:25 pmRNSDirector/PDMR Shareholding
8th May 20264:20 pmRNSDirector/PDMR Shareholding
8th May 202610:55 amRNSDirector/PDMR Shareholding
8th May 202610:50 amRNSDirector/PDMR Shareholding
7th May 20266:15 pmRNSPublication of Final Terms
5th May 20262:15 pmRNSTransaction in Own Shares
5th May 202611:00 amRNSDirector/PDMR Shareholding
1st May 202611:50 amRNSIssue of Shares
1st May 202611:45 amRNSTotal Voting Rights
30th Apr 20263:45 pmRNSDirector/PDMR Shareholding
27th Apr 202612:00 pmRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:05 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSShare Buyback Programme
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 202610:15 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20263:30 pmRNSResult of AGM
15th Apr 202611:45 amRNSAGM Statement
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:00 pmRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 202611:45 amRNSDirector/PDMR Shareholding
9th Apr 20267:05 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirectorate change
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20262:35 pmRNSTotal Voting Rights and Issue of Shares
1st Apr 20262:30 pmRNSDirector/PDMR Shareholding
1st Apr 202611:05 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.